Trifecta Capital Advisors, LLC Ark Genomic Revolution ETF (De Transaction History
Trifecta Capital Advisors, LLC
- $478 Billion
- Q3 2024
A detailed history of Trifecta Capital Advisors, LLC transactions in Ark Genomic Revolution ETF (De stock. As of the latest transaction made, Trifecta Capital Advisors, LLC holds 465 shares of ARKG stock, worth $11,080. This represents 0.0% of its overall portfolio holdings.
Number of Shares
465
Previous 465
-0.0%
Holding current value
$11,080
Previous $10.9 Million
9.02%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ARKG
# of Institutions
287Shares Held
24.5MCall Options Held
3.02MPut Options Held
2.65M-
Jpmorgan Chase & CO New York, NY2.96MShares$70.4 Million0.01% of portfolio
-
Bank Of America Corp Charlotte, NC2.9MShares$69.2 Million0.01% of portfolio
-
Main Management ETF Advisors, LLC San Francisco, CA2.43MShares$57.9 Million2.95% of portfolio
-
Goldman Sachs Group Inc New York, NY1.81MShares$43.2 Million0.01% of portfolio
-
Citigroup Inc1.68MShares$40 Million0.03% of portfolio